Your session is about to expire
← Back to Search
Anesthetics for Pain Management During Surgery (MCA Trial)
MCA Trial Summary
This trial will test how pain affects long-term memory and the body's conditioned responses, using MRI to track the brain's reaction. The study will take place over 5 visits, with no long-term follow up required.
MCA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMCA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MCA Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am generally healthy without major chronic diseases.I am currently taking medication for mood, anxiety, sleep, or pain.I have a history of neurological or psychiatric conditions, including benign tremor.I have a history of serious lung disease.I have been diagnosed with obstructive sleep apnea.You are afraid of small, enclosed spaces.I have a long-term pain condition.I have diabetes or nerve damage.You are pregnant.You have a past of using drugs for non-medical purposes.My BMI is either above 35 or below 18.You must have a healthy body weight.I am between 18 and 39 years old, speak English natively, and have finished high school.I have significant memory or hearing problems.I have a working email and phone number.I have a history of serious heart problems, like high blood pressure or irregular heartbeat.You have a medical device implanted in your body that runs on electricity.You have metal inside your body that cannot be safely scanned using an MRI machine.My hearing and memory are normal.
- Group 1: Dexmedetomidine
- Group 2: Propofol
- Group 3: Fentanyl
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open enrollment opportunities for this clinical trial?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively seeking participants since its initial posting on July 30th 2020 and most recent update on September 6th 2022. 150 people are needed from a single location for the study."
Does this research program accept participants younger than eighty years of age?
"Candidates aged between 18 and 39 years old are desired for this clinical trial."
What possible deleterious effects may result from Peripheral Nerve Stimulation?
"With reference to the limited data avaialble, our experts at Power assigned Peripheral Nerve Stimulation a safety score of 1. This is due to its status as an early-phase trial and lack of supporting evidence for both efficacy and safety."
In what therapeutic contexts is Peripheral Nerve Stimulation commonly employed?
"Peripheral Nerve Stimulation can be employed for monitored anesthesia care therapy and has been used to relieve pain from a variety of states, including anesthetics, conduction block, and general anaesthesia."
Who meets the criteria for enrollment in this trial?
"This clinical trial requires potential participants to have a history of pain, with ages ranging from 18 - 39 years old. 150 individuals will be selected in total."
How many people are participating in this trial at its peak?
"Affirmative. According to the records hosted on clinicaltrials.gov, this medical trial is actively seeking out participants and was initially posted on July 30th 2020 with a recent update occurring September 6th 2022. The researchers are hoping to secure 150 patients from one site for the study's duration."
Could you provide a synopsis of the other experiments conducted on Peripheral Nerve Stimulation?
"Currently, 205 clinical trials related to Peripheral Nerve Stimulation are being conducted. Out of these studies, 43 have reached the third stage of development. All investigations into this therapy originate in Karachi, Sindh but span across 463 locations worldwide."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger